Literature DB >> 16864941

Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers.

Weon Kim1, Myung Ho Jeong, Suk Hee Cho, Ji Hye Yun, Hong Jae Chae, Young Keun Ahn, Min Cheol Lee, Xianwu Cheng, Takahisa Kondo, Toyoaki Murohara, Jung Chaee Kang.   

Abstract

BACKGROUND: The present study was designed to investigate the effect and relationship of endothelial function and endothelial progenitor cells (EPCs) by green tea consumption in chronic smokers. The numbers of circulating EPCs have an inverse correlation with chronic smoking and endothelial dysfunction. Green tea catechin improved endothelial dysfunction in chronic smokers. METHOD AND
RESULTS: In 20 young healthy smokers, endothelial functions, defined by flow-mediated endothelium dependent vasodilation (FMD) of the brachial artery via ultrasound as well as the number of EPCs isolated from peripheral blood, were determined at baseline and at 2 weeks after green tea consumption (8 g/day). Circulating EPCs were quantified by flow cytometry as CD45lowCD34+KDR2+ cells and by acyl-low-density lipoprotein and fluorescein isotiocyanate-lectin double positive cells after culture for 7 days. Clinical characteristics and laboratory findings were not significantly different between the baseline and at 2 weeks after green tea intake. EPC levels were inversely correlated with the number of cigarettes smoked. Circulating EPCs by flow cytometry (78.6+/-72.6 vs 156.1+/-135.8 /ml, p<0.001) and cultured EPCs (118.2+/-35.7 vs 169.31+/-58.3/10 field, p<0.001) increased rapidly at 2 weeks after green tea consumption. FMD was significantly improved after 2 weeks (7.2+/-2.8 vs 9.3+/-2.4, p<0.001). The FMD correlated with EPC counts (r=0.67, p=0.003) before treatment and after 2 weeks (r=0.60, p=0.013).
CONCLUSIONS: A short-term administration of green tea consumption induces a rapid improvement of EPC levels and FMD. Green tea consumption may be effective to prevent future cardiovascular events in chronic smokers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864941     DOI: 10.1253/circj.70.1052

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  18 in total

1.  Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats.

Authors:  A Gokulakrisnan; B Jayachandran Dare; C Thirunavukkarasu
Journal:  Mol Cell Biochem       Date:  2011-06-03       Impact factor: 3.396

2.  Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients.

Authors:  Lu-lu Chen; Yun-fei Liao; Tian-shu Zeng; Fan Yu; Hui-qing Li; Yong Feng
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 3.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

4.  Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.

Authors:  Arpita Basu; Mei Du; Karah Sanchez; Misti J Leyva; Nancy M Betts; Steve Blevins; Mingyuan Wu; Christopher E Aston; Timothy J Lyons
Journal:  Nutrition       Date:  2010-06-02       Impact factor: 4.008

Review 5.  Tea and cardiovascular disease.

Authors:  Apranta Deka; Joseph A Vita
Journal:  Pharmacol Res       Date:  2011-04-06       Impact factor: 7.658

6.  Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals.

Authors:  Kirstin Aschbacher; Qiumei Chen; Monika Varga; Daniel J Haddad; Yerem Yeghiazarians; Elissa Epel; Owen M Wolkowitz; Matthew L Springer
Journal:  Am J Cardiovasc Dis       Date:  2011-10-03

Review 7.  Green tea catechins and cardiovascular health: an update.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 8.  The vascular endothelium in diabetes--a therapeutic target?

Authors:  Kieren J Mather
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

Review 9.  Assessment of endothelial dysfunction in childhood obesity and clinical use.

Authors:  Luc Bruyndonckx; Vicky Y Hoymans; Amaryllis H Van Craenenbroeck; Dirk K Vissers; Christiaan J Vrints; José Ramet; Viviane M Conraads
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

10.  Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension.

Authors:  Weon Kim; Myong Joo Hong; Jong Shin Woo; Won Yu Kang; Sun Ho Hwang; Wan Kim
Journal:  Chonnam Med J       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.